Inventor · disambiguated record
Taisheng Huang
Also filed as: HUANG TAISHENG
21 granted patents·10 pending applications·311 citations·filing 2005–2025
95Inventor score
Top patents by PatentIndex Score
31 records- 0199US11285140B2Piperidin-4-yl azetidine derivatives as JAK1 inhibitorsINCYTE CORP·Filed 2020·Granted Mar 29, 2022·14 cites·2 claims
- 0298US9999619B2Piperidin-4-yl azetidine derivatives as JAK1 inhibitorsINCYTE CORP·Filed 2016·Granted Jun 19, 2018·38 cites·2 claims
- 0398US9464088B2Piperidin-4-yl azetidine derivatives as JAK1 inhibitorsINCYTE CORP·Filed 2014·Granted Oct 11, 2016·57 cites·49 claims
- 0497US10695337B2Piperidin-4-yl azetidine derivatives as JAK1 inhibitorsINCYTE CORP·Filed 2018·Granted Jun 30, 2020·21 cites·14 claims
- 0597US8765734B2Piperidin-4-yl azetidine derivatives as JAK1 inhibitorsHUANG TAISHENG·Filed 2011·Granted Jul 1, 2014·116 cites·12 claims
- 0695US11390624B2Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitorsINCYTE CORP·Filed 2020·Granted Jul 19, 2022·4 cites·42 claims
- 0794US11673894B2Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitorsINCYTE CORP·Filed 2020·Granted Jun 13, 2023·4 cites·25 claims
- 0894US10053465B2Pyrrolopyrimidine derivatives as TAM inhibitorsINCYTE CORP·Filed 2016·Granted Aug 21, 2018·16 cites·37 claims
- 0992US10000507B2Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Jun 19, 2018·12 cites·18 claims
- 1091US9556197B2Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2014·Granted Jan 31, 2017·19 cites·48 claims
- 1184US7678798B2Piperazinylpiperidine derivatives as chemokine receptor antagonistsINCYTE CORP·Filed 2005·Granted Mar 16, 2010·5 cites·35 claims
- 1282US12415809B2Pyrrolotriazine compounds as tam inhibitorsINCYTE CORP·Filed 2023·Granted Sep 16, 2025·0 cites·33 claims
- 1380US2023357255A1Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitorsINCYTE CORP·Filed 2023·Application pending·0 cites
- 1479US8268826B2Piperazinylpiperidine derivatives as chemokine receptor antagonistsXUE CHU-BIAO·Filed 2009·Granted Sep 18, 2012·3 cites·17 claims
- 1577US2023043959A1Piperidin-4-yl azetidine derivatives as jak1 inhibitorsINCYTE CORP·Filed 2022·Application pending·0 cites
- 1676US8362003B23-aminopyrrolidine derivatives as modulators of chemokine receptorsINCYTE CORP·Filed 2011·Granted Jan 29, 2013·2 cites·8 claims
- 1776US2025041310A1Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 InhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 1875US11884665B2Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitorsINCYTE CORP·Filed 2022·Granted Jan 30, 2024·0 cites·12 claims
- 1975US2025313567A1Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitorsINCYTE CORP·Filed 2025·Application pending·0 cites
- 2075US2025059293A1Cd73 inhibitor and a2a/a2b adenosine receptor inhibitor combination therapyINCYTE CORP·Filed 2024·Application pending·0 cites
- 2168US2025163079A1Kras inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 2265US2022213112A1Pyrrole tricyclic compounds as a2a / a2b inhibitorsINCYTE CORP·Filed 2021·Application pending·0 cites
- 2362US12060433B2CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapyINCYTE CORP·Filed 2020·Granted Aug 13, 2024·0 cites·39 claims
- 2461US9067921B2Piperazinylpiperidine derivatives as chemokine receptor antagonistsINCYTE CORP·Filed 2014·Granted Jun 30, 2015·0 cites·7 claims
- 2561US2021205311A1Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 InhibitorsINCYTE CORP·Filed 2020·Application pending·0 cites
- 2660US11220510B2Pyrrole tricyclic compounds as A2A / A2B inhibitorsINCYTE CORP·Filed 2019·Granted Jan 11, 2022·0 cites·2 claims
- 2760US2019292188A1Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitorsINCYTE CORP·Filed 2019·Application pending·0 cites
- 2858US11767320B2Bicyclic dione compounds as inhibitors of KRASINCYTE CORP·Filed 2021·Granted Sep 26, 2023·0 cites·37 claims
- 2958US2022233529A1Combination therapy comprising a2a/a2b inhibitors, pd-1/pd-l1 inhibitors, and anti-cd73 antibodiesINCYTE CORP·Filed 2021·Application pending·0 cites
- 3057US8680104B2Piperazinylpiperidine derivatives as chemokine receptor antagonistsXUE CHU-BIAO·Filed 2012·Granted Mar 25, 2014·0 cites·9 claims
- 3140US8895571B2Isoindolinone and pyrrolopyridinone derivatives as Akt inhibitorsINCYTE CORP·Filed 2012·Granted Nov 25, 2014·0 cites·35 claims
Join the waitlist — get patent alerts
Get an alert when Taisheng Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →